google-site-verification: googlec7193c3de77668c9.html

FDA approves gene therapy for severe leukocyte adhesion deficiency-I, a rare immune disorder

[
Dr. Donald Kohn has been developing gene therapies for rare pediatric immune disorders for over 30 years. This week, his role in a clinical trial has culminated in the first-ever U.S. Food and Drug Administration–approved therapy for severe leukocyte adhesion deficiency-I—a genetic condition characterized by recurrent infections and, often, early death.


Source link

Advertisements
Views: 3

See also  Researchers identify deletions in long noncoding RNA that lead to severe neurodevelopmental disorder

Check Also

Are your meds and DNA a bad match? This test alerts clinicians

[ Credit: Pixabay/CC0 Public Domain Differences in people’s genes can affect how they respond to …

The magic of mushrooms: Psychedelic psilocybin shows promise for treating cocaine addiction

[ Cocaine addiction treatment has found a surprising new contender in the highly regulated substance …

Data hidden in tuberculosis screening tests shed light on patients’ overall mortality

[ Credit: Unsplash/CC0 Public Domain Scientists have long known that the immune system plays a …

Leave a Reply

Available for Amazon Prime
Com – eric latek. Just a moment....